HTSC(SH:601688) Mei Ri Jing Ji Xin Wen·2025-05-21 03:10Group 1 - The overall performance of the Shanghai Stock Exchange Science and Technology Innovation Board Composite Index showed a decline of 0.42% as of May 21 [1] - Among the constituent stocks, Sanofi Biologics reached the daily limit increase, while China Post Technology and Haichuang Pharmaceutical rose by 9.34% and 8.00% respectively; on the downside, Liyang Chip led the decline at 6.43% [1] - The Huaxia Science and Technology Innovation Index ETF (589000) experienced a decrease of 0.43%, with the latest price at 0.94 yuan [1] Group 2 - Huatai Securities believes that the science and technology sector still holds certain allocation value, citing the current weak stabilization of the inventory cycle and ongoing capacity clearance in the A-share market [2] - The report highlights that with the phase agreement on tariffs between China and the US, global capital market investors' risk appetite is expected to recover, which may increase attention on the technology sector [2] - The Huaxia Science and Technology Innovation Index ETF closely tracks the Shanghai Stock Exchange Science and Technology Innovation Board Composite Index, focusing on hard technology fields such as new generation information technology, high-end equipment, biomedicine, new energy, new materials, and energy conservation and environmental protection [2]